AusPAR: Imjudo

Australian Public Assessment Report

AusPAR

AusPAR: Imjudo [PDF, 1.2 MB]

AusPAR: Imjudo [Word, 4.44 MB]

Attachment Product information for Imjudo [PDF, 343.84 KB]

Attachment Product information for Imjudo [Word, 217.35 KB]

Device/Product Name

Imjudo

Active ingredients

Tremelimumab

AusPAR Date

8 December 2023

Published

20 December 2023

Submission Number

PM-2022-01514-1-4

Submission Type

New biological entity

Decision

Approved